Icon-testtube Copy Created with Sketch.

In Vitro Diagnostics | Research, Development, Test, and Evaluation

Emerging Infectious Disease

MRIGlobal’s emerging infectious disease services span all stages of the in vitro diagnostic product development process, beginning with research and development.

Our infectious disease diagnostics research includes development of methods, platforms, and molecular and immunological assays. These services provide a turnkey, outsourcing solution for commercial companies and government agencies seeking to accelerate product development into later clinical verification and validation phases.

Capabilities

MRIGlobal offers comprehensive assay and protocol development for the diagnosis of emerging infectious disease:

Molecular and immunological

Next Generation Sequencing

Advanced bioinformatics

Prototype development of sample collection, testing, preservation, and transport solutions for austere, non-conventional, and traditional laboratories

Our Staff

Kyle Parker inspects a reagent cartridge prior to loading clinical samples for analysis with a point-of-care device.

MRIGlobal scientists conduct research and development with commercial companies to improve emerging infectious disease diagnostic technologies with the goal of advancing these technologies into verification and validation phases of clinical product development.

Photo of Kyle Parker inspecting a reagent cartridge prior to loading clinical samples for analysis with a point-of-care device.

Work with us

MRIGlobal looks forward to contributing our expertise where it matters most.

Use our Project Quote Tool to learn more about how we can help with your next endeavor.

Project Quote Tool

See Our Certifications

See Our Facilities